共 50 条
New Developments in Insomnia Medications of Relevance to Mental Health Disorders
被引:9
|作者:
Krystal, Andrew D.
[1
]
机构:
[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA
关键词:
Personalization;
Insomnia;
Comorbid psychiatric disorders;
Suvorexant;
Doxepin;
Prazosin;
Eszopiclone;
POSTTRAUMATIC-STRESS-DISORDER;
DOXEPIN;
MG;
GENERALIZED ANXIETY DISORDER;
PLACEBO-CONTROLLED TRIAL;
DOUBLE-BLIND;
COMBAT VETERANS;
SLEEP DISTURBANCE;
TRAUMA NIGHTMARES;
EFFICACY;
SAFETY;
D O I:
10.1016/j.psc.2015.08.001
中图分类号:
R749 [精神病学];
学科分类号:
100205 ;
摘要:
Many insomnia medications with high specificity have become available recently. They provide a window into the clinical effects of modulating specific brain systems and establish a new guiding principal for conceptualizing insomnia medications: "mechanism matters." A new paradigm for insomnia therapy in which specific drugs are selected to target the specific type of sleep difficulty for each patient includes administering specific treatments for patients with insomnia comorbid with particular psychiatric disorders. This article reviews insomnia medications and discusses the implications for optimizing the treatment of insomnia occurring comorbid with psychiatric conditions.
引用
收藏
页码:843 / +
页数:19
相关论文